Nature's Sunshine Products/$NATR
1D1W1MYTD1Y5YMAX
Capital at risk
About Nature's Sunshine Products
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
- Ticker
- $NATR
- Sector
- Consumer Essentials
- Primary listing
- NASDAQ
- Employees
- 806
- Headquarters
- Lehi, United States
- Website
- www.naturessunshine.com
NATR Metrics
BasicAdvanced
$229M
13.02
$1.00
0.85
-
Price and volume
Market cap
$229M
Beta
0.85
52-week high
$28.14
52-week low
$12.80
Average daily volume
221K
Financial strength
Current ratio
2.595
Quick ratio
1.402
Long term debt to equity
0.1
Total debt to equity
0.127
Interest coverage (TTM)
207.96%
Profitability
EBITDA (TTM)
42.692
Gross margin (TTM)
73.16%
Net profit margin (TTM)
3.68%
Operating margin (TTM)
5.96%
Effective tax rate (TTM)
34.78%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
7.12%
Return on equity (TTM)
11.23%
Valuation
Price to earnings (TTM)
13.024
Price to revenue (TTM)
0.466
Price to book
1.35
Price to tangible book (TTM)
1.35
Price to free cash flow (TTM)
12.682
Free cash flow yield (TTM)
7.89%
Free cash flow per share (TTM)
1.027
Growth
Revenue change (TTM)
6.77%
Earnings per share change (TTM)
33.53%
3-year revenue growth (CAGR)
4.40%
10-year revenue growth (CAGR)
4.03%
3-year earnings per share growth (CAGR)
54.27%
10-year earnings per share growth (CAGR)
5.58%
What the Analysts think about NATR
Analyst ratings (Buy, Hold, Sell) for Nature's Sunshine Products stock.
Analyst projections of the future price of Nature's Sunshine Products stock.
NATR Financial Performance
Revenues and expenses
NATR Earnings Performance
Company profitability
Upcoming events
No upcoming events
NATR News
AllArticlesVideos
Funds containing NATR
Fund name | Fund size | $NATR weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.